This inventor holds 1 USPTO granted patent. Top assignee: Kanebo, Limited. Active years: 1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988
Title: Yoichiro Hamada: Innovator in Pharmaceutical Chemistry
Introduction
Yoichiro Hamada is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on benzylpiperazine compounds.
Latest Patents
Hamada holds a patent for a novel benzylpiperazine compound, which is characterized by its excellent hypolipidemic activity. This compound is designed to be used in pharmaceutical compositions suitable for the prophylaxis and treatment of hyperlipidemia. The patent emphasizes the compound's effectiveness without undesirable side effects, making it a valuable addition to medical treatments.
Career Highlights
Hamada is associated with Kanebo, Limited, where he has been instrumental in advancing research and development in pharmaceutical applications. His work has not only contributed to the company's portfolio but has also had a broader impact on the industry.
Collaborations
Throughout his career, Hamada has collaborated with esteemed colleagues such as Hiroshi Ohtaka and Akira Yamashita. These partnerships have fostered innovation and have led to advancements in their respective fields.
Conclusion
In summary, Yoichiro Hamada is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the treatment of hyperlipidemia. His contributions continue to influence the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile